In this interview, Tim Joye discusses the importance of shifting from private pharmaceutical production to public ownership, emphasizing the need to regain control over medicines’ development and production, while also boosting the need for local production. Highlighting examples and challenges, it underscores the necessity for public alternatives to address pricing, shortages, and innovation in crucial […]
